Highlights CSL Limited

Stocks

CSL

AU000000CSL8

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 02:19:41 2026-06-11 am EDT			5-day change	1st Jan Change
107.23 ^AUD	+4.16%		+16.25%	-37.89%

Jun. 08	CSL Unit Signs Five-Year Lease Contract with Clever Culture Systems for APAS Independence Instrument	MT
Jun. 04	ASX Midday Sector Update: Healthcare Stocks Jump, Materials Sector Struggles	MT

Highlights

Jun. 08	CSL Unit Signs Five-Year Lease Contract with Clever Culture Systems for APAS Independence Instrument	MT
May. 27	CSL Says CEO Indirectly Acquires Nearly AU$108,000 Worth of Shares	MT
May. 27	Australia's Therapeutic Goods Administration says Seqirus to discontinue Benpen injection products	RE
May. 27	CSL's Seqirus to discontinue bacterial infection drug amid generic competition	RE
May. 27	Australia says CSL unit Seqirus to discontinue Benpen injections from November	RE
May. 11	CSL's Fiscal-Year Earnings Guidance Downgrade Not Surprising, Jefferies Says	MT
May. 10	CSL Cuts Fiscal 2026 Outlook, Flags $5 Billion of Additional Impairments; Shares Hit Nine-Year Low	MT
May. 10	Australia's CSL plunges on outlook cut, $5 billion impairment warning	RE
May. 10	CSL expects FY26 revenue $15.2 bln, NPATA $3.1 bln at constant currency	RE
May. 10	Australia's CSL cuts 2026 earnings forecast as payoff from growth initiatives delayed	RE
May. 10	CSL Limited Provides Earnings Guidance for FY2026	CI
May. 10	CSL Cuts Annual Guidance, Signals $5 Billion of New Impairments -- Update	DJ
May. 10	CSL Cuts Annual Guidance, Signals $5 Billion of New Impairments	DJ
Apr. 22	CSL Shares Hit Nearly 9-Year Low as US Drops Flu Vaccine Mandate	MT
Mar. 09	CSL Shares Rise After Manufacturing Facility Expansion Announcement	MT
Mar. 09	For interim dividend	FA
Mar. 09	CSL Announces Expansion of Illinois Plasma Therapy Manufacturing Facility with $1.5 Billion Investment	CI
Mar. 04	CSL Secures Canada Pandemic Influenza Vaccine Supply Contract, AFR Says	MT
Feb. 23	Australian shares dip on U.S. tariff jitters; miners buck the trend	RE
Feb. 17	CSL Enters Licensing Deal With Eli Lilly	MT
Feb. 15	CSL Unit Says Nasal Spray Product Approved for Use in Australia	MT
Feb. 15	Csl says neffy, adrenaline nasal spray, approved to treat anaphylaxis in Australia	RE
Feb. 10	CSL's Fiscal H1 EBIT Boosted by Cost Reductions, Jarden Says	MT
Feb. 10	CSL Posts Lower Fiscal H1 Underlying Earnings, Revenue; Reaffirms Fiscal 2026 Outlook; Shares Hit Eight-Year Low	MT
Feb. 10	Australian biotech firm CSL tanks 17% after CEO departure, weak first-half earnings	RE